Inhibition of catechol-o-methyltransferase (COMT) by myricetin, dihydromyricetin and myricitrin

Pharmazie

Volumn 69, Issue 3, 2014, Pages 183-186

  Zhu, Xu ^a   Jia, Yun Hong ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMPELOPSIN; CATECHOL METHYLTRANSFERASE; FLAVONE DERIVATIVE; MYRICETIN; MYRICETIN 3 RHAMNOSIDE; UNCLASSIFIED DRUG;

ARTICLE; DEGLYCOSYLATION; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; LIVER CYTOSOL; METHYLATION; MYRICA RUBRA; MYRICACEAE;

CATECHOL O-METHYLTRANSFERASE; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLAVONOIDS; FLAVONOLS; HUMANS; INDICATORS AND REAGENTS; KINETICS; LEVODOPA; LIVER; METHYLATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84897141360     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2014.3840     Document Type: Article

References (20)

1. Axelrod J (1957) O-Methylation of epinephrine and other catechols in vitro and in vivo. Science 126: 400-401.
2. Bonifacio MJ, Palma PN, Almeida L, Soares-da-Silva P (2007) Catechol-O-methyltransferase and Its Inhibitors in Parkinson's Disease. CNS Drug Rev 13: 352-379. (Pubitemid 47481088)
3. Borchardt RT (1973) Catechol O-methyltransferase. 1. Kinetics of tropolone inhibition. J Med Chem 16: 377-382.
4. Borchardt RT, Huber JH, HoustonM(1982) Catechol O-methyltransferase. 10. 5-Substituted, 3-hydroxy-4-methoxybenzoic acids (isovanillic acids) and 5-substituted, 3-hydroxy-4-methoxybenzaldehydes (isovanillins) as potential inhibitors. J Med Chem 25: 258-263. (Pubitemid 12158026)
5. DeRuiter J, Davis RA, Wandrekar VG, Mayfield CA (1991) Relative structure-inhibition analyses of the N-benzoyl and N-(phenylsulfonyl) amino acid aldose reductase inhibitors. J Med Chem 34: 2120-2126.
6. Dong RH, Fang ZZ, Zhu LL, Ge GB, Li XB, Hu CM, Cao YF, Xia YL, Yang L, Liu ZY (2013) Deep understanding of the interaction between thienorphine and UDP-glucuronosyltransferase (UGT) isoforms. Xenobiotica 43: 133-139.
7. Fang ZZ, Cao YF, Hu CM, Hong M, Sun XY, Ge GB, Liu Y, Zhang YY, Yang L, Sun HZ (2013) Structure-inhibition relationship of ginsenosides towards UDP-glucuronosyltransferases (UGTs). Toxicol Appl Pharmacol 267: 149-154.
8. Fang ZZ, Zhang YY, Ge GB, Liang SC, Sun DX, Zhu LL, Dong PP, Cao YF, Yang L (2011) Identification of cytochrome P450 (CYP) isoforms involved in the metabolism of corynoline, and assessment of its herb-drug interactions. Phytother Res 25: 256-263.
9. Huang T, Fang Z,Yang L (2010) Strong inhibitory effect of medroxyprogesterone acetate (MPA) on UDP-glucuronosyltransferase (UGT) 2B7 might induce drugdrug interactions. Pharmazie 65: 919-921.
10. Kang KS, Wen Y, Yamabe N, Fukui M, Bishop SC, Zhu BT (2010) Dual beneficial effects of (-)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration: in vitro and in vivo studies. PLoS One 5: e11951.
11. Matkowski A, Jamiolkowska-Kozlowska W, Nawrot I (2013) Chinese medicinal herbs as source of antioxidant compounds-where tradition meets the future. Curr Med Chem 20: 984-1004.
12. Nyholm D, Johansson A, Lennernas H, Askmark H (2012) Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial. Eur J Neurol 19: 820-826.
13. Reches A, Jiang D-H, Fahn S (1982) Effect of 3′, 4′-dihydroxy-2-methylpropriophenone (U-0521) on catechol-O- methyltransferase activity and on DOPA accumulation in rat red blood cells and corpus striatum. Biochem Pharmacol 31: 3415-3418. (Pubitemid 13234502)
14. Ross S, Haljasmaa O (1964) Catechol-O-Methyl transferase inhibitors. In vitro inhibition of the enzyme in mouse-brain extract. Acta Pharmacol Toxicol 21: 205-214.
15. Shen Y, Lindemeyer AK, Gonzalez C, Shao XM, Spigelman I, Olsen RW, Liang J (2012) Dihydromyricetin as a novel anti-alcohol intoxication medication. J Neurosci 32: 390-401.
16. Song JH, Fang ZZ, Zhu LL, Cao YF, Hu CM, Ge GB, Zhao DW (2013) Glucuronidation of the broad-spectrum antiviral drug arbidol by UGT isoforms. J Pharm Pharmacol 65: 521-527.
17. Sun F, Zheng XY, Ye J, Wu TT, Wang JI, Chen W (2012) Potential anticancer activity of myricetin in human t24 bladder cancer cells both in vitro and in vivo. Nutrition Cancer 64: 599-606.
18. Takahashi E, Arimoto S, Okamoto K, Negishi T (2007) Enhancement of phase II enzyme activity by purpurin resulting in the suppression of MeIQx-DNA-adduct formation in mice. Mutat Res 626: 128-134. (Pubitemid 44881414)
19. Wang S-J, Tong Y, Lu S, Yang R, Liao X, Xu YF, Li X (2010) Anti-inflammatory activity of myricetin isolated from Myrica rubra Sieb. et Zucc. leaves. Planta Med 76: 1492-1496.
20. Zhu BT, Wang P, Nagai M, Wen Y, Bai HW (2009) Inhibition of human catechol-O-methyltransferase (COMT)-mediated O-methylation of catechol estrogens by major polyphenolic components present in coffee. J Steroid Biochem Mol Biol 113: 65-74.